From a biochemical pharmacy standpoint, Relafen 750 ( Naproxen Acid) presents a fascinating case study in medication action. Its mechanism of action primarily involves the suppression of cyclooxygenase ( COX enzymes ) enzymes, particularly the COX-2 isoform, leading to a reduction in the synthesis of inflammatory mediators. This targeted inhibition